Literature DB >> 1952296

Evaluation of the burden of illness for pediatric asthmatic patients and their parents.

M Townsend1, D H Feeny, G H Guyatt, W J Furlong, A E Seip, J Dolovich.   

Abstract

To examine the quality-of-life burden of asthma in a pediatric population, we systematically surveyed 100 patients with moderate asthma and one parent of each patient to determine the impact of the disease on day-to-day life. We found that perceptions of burden of illness varied by viewpoint. For patients, the symptoms of asthma form the largest component of the burden of the disease; in addition, more than half of the sample listed various emotional function items that were of at least moderate bother to them. Parents cited worry and concern about the disease and the medications used to treat it and their inability to relieve their child's symptoms as the major components of the burden of the disease. We conclude that although pediatric patients with moderate asthma find the respiratory symptoms of the disease troublesome, few children perceive that their asthma poses a major disruption of their lives. For the parents of these patients, strategies could be implemented by clinicians to ease the common worries and concerns surrounding the child's asthma.

Entities:  

Mesh:

Year:  1991        PMID: 1952296

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  22 in total

Review 1.  Quality-of-life considerations in the treatment of asthma.

Authors:  E F Juniper
Journal:  Pharmacoeconomics       Date:  1995-08       Impact factor: 4.981

2.  Measuring quality of life in children with asthma.

Authors:  E F Juniper; G H Guyatt; D H Feeny; P J Ferrie; L E Griffith; M Townsend
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

3.  Health-related quality of life in Australian children with asthma: lessons for the cross-cultural use of quality of life instruments.

Authors:  D J French; A Carroll; M J Christie
Journal:  Qual Life Res       Date:  1998-07       Impact factor: 4.147

Review 4.  Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.

Authors:  H M Lamb; C R Culy; D Faulds
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

5.  Measuring quality of life in the parents of children with asthma.

Authors:  E F Juniper; G H Guyatt; D H Feeny; P J Ferrie; L E Griffith; M Townsend
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

6.  Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.

Authors:  T Volmer; A Kielhorn; H H Weber; K J Wiessmann
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

7.  Reliability and validity of childhood asthma control test in a population of Chinese asthmatic children.

Authors:  Hsin-Hung Chen; Jiu-Yao Wang; Ren-Long Jan; Yi-Hsun Liu; Li-Fan Liu
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

8.  Assessing the burden of childhood asthma: validation of electronic versions of the Mini Pediatric and Pediatric Asthma Caregiver's Quality of Life Questionnaires.

Authors:  Janice P Minard; Nicola J Thomas; Jennifer G Olajos-Clow; Nastasia V Wasilewski; Blaine Jenkins; Ann K Taite; Andrew G Day; M Diane Lougheed
Journal:  Qual Life Res       Date:  2015-07-28       Impact factor: 4.147

9.  Health-related quality of life in children assessed by their parents: evaluation of the psychometric properties of the CHQ-PF50 in two German clinical samples.

Authors:  Petra Warschburger; Jeanne M Landgraf; Franz Petermann; Klaus Freidel
Journal:  Qual Life Res       Date:  2003-05       Impact factor: 4.147

10.  How does asthma influence the daily life of children? Results of focus group interviews.

Authors:  Lisette van den Bemt; Sabine Kooijman; Vinca Linssen; Peter Lucassen; Jean Muris; Gordon Slabbers; Tjard Schermer
Journal:  Health Qual Life Outcomes       Date:  2010-01-14       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.